Abstract
Pleomorphic xanthoastrocytoma (PXA) is a rare tumor with favorable prognosis, classified as grade II in the World Health Organization (WHO) and accounts for less than 1% of all astrocytic neoplasm. It is commonly found in childhood and young adults. This tumor has been described as part of the spectrum of Long-Term Epilepsy Associated Tumors (LEAT). The most common location is supratentorial, involving predominantly the temporal lobe.
Highlights
Pleomorphic xanthoastrocytoma (PXA) is a rare tumor with favorable prognosis, classified as grade II in the World Health Organization (WHO) and accounts for less than 1% of all astrocytic neoplasms [1,2]
There is no reported prevalence in the Mexican population because, as in the world, few cases exist in the literature
Seizures are the most common symptom of PXA. This tumor has been described as part of the spectrum of Long-Term Epilepsy Associated Tumors (LEAT), which involves lesions identified in patients with two or more years of drug-resistant epilepsy [8]
Summary
Pleomorphic xanthoastrocytoma (PXA) is a rare tumor with favorable prognosis, classified as grade II in the World Health Organization (WHO) and accounts for less than 1% of all astrocytic neoplasms [1,2]. It is commonly found in childhood and young adults [3]. Seizures are the most common symptom of PXA This tumor has been described as part of the spectrum of Long-Term Epilepsy Associated Tumors (LEAT), which involves lesions identified in patients with two or more years of drug-resistant epilepsy [8]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
